infectious-disease obstetrics immunology
Toxoplasmosis Risk Assessment (Congenital and Immunocompromised)
Assesses risk of active or congenital toxoplasmosis. Guides spiramycin/pyrimethamine-sulphadiazine therapy and neonatal screening.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Methotrexate (Dermatology — Psoriasis) · Disease-Modifying Antirheumatic / Immunosuppressant
- Acetazolamide (Ménière's Disease) · Carbonic Anhydrase Inhibitor (Diuretic)
- Zinc acetate · Zinc salt (Wilson's disease)
- Sulfasalazine · Aminosalicylate / Disease-Modifying Antirheumatic Drug (DMARD)
- Hydroxycarbamide (Hydroxyurea) · Cytoreductive agent / Sickle cell disease / CML
- Hydroxycarbamide (Hydroxyurea) · Cytotoxic / Disease-Modifying Agent
Pathways
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.